What was the market valuation of the US digital therapeutics market in 2024?

The market valuation was $2800.0 Million in 2024. Read More

What is the projected market valuation for the US digital therapeutics market by 2035?

The projected valuation for 2035 is $23500.0 Million. Read More

What is the expected CAGR for the US digital therapeutics market during the forecast period 2025 - 2035?

The expected CAGR is 21.34% during the forecast period 2025 - 2035. Read More

Which therapeutic areas are expected to drive growth in the US digital therapeutics market?

Key therapeutic areas include Neurology, Cardiology, Diabetes, and Oncology. Read More

What are the main segments of the US digital therapeutics market?

The main segments include Application, Delivery Mode, and End User. Read More

How did the Chronic Disease Management segment perform in 2024?

The Chronic Disease Management segment was valued at $800.0 Million in 2024. Read More

What is the projected value of the Mental Health Disorders segment by 2035?

The projected value for the Mental Health Disorders segment is $7000.0 Million by 2035. Read More

Which delivery mode segment had the highest valuation in 2024?

The Platform delivery mode segment had the highest valuation at $1400.0 Million in 2024. Read More

Who are the key players in the US digital therapeutics market?

Key players include Omada Health, Pear Therapeutics, Big Health, and Akili Interactive. Read More

What was the valuation of the Device delivery mode segment in 2024?

The Device delivery mode segment was valued at $840.0 Million in 2024. Read More

US Digital Therapeutics Market

US Digital Therapeutics Market Research Report: Size, Share, Trend Analysis By Applications (Chronic Disease Management, Mental Health Disorders, Preventive Care, General Wellness), By Delivery Mode (Software, Device, Platform), By End Users (Patients, Providers, Payers, Employers) and By Therapeutic Area (Diabetes, Cardiology, Neurology, Oncology) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

21.34%

2024 Market Size

$ 2,800 Million

2035 Market Size

$ 23,500 Million

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/16404-HCR | Pages: 100 | Author: Satyendra Maurya, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Industrial Automation & Equipment, BY Application (USD Million) | |
  1. 4.1.1 Chronic Disease Management | |
  2. 4.1.2 Mental Health Disorders | |
  3. 4.1.3 Preventive Care | |
  4. 4.1.4 General Wellness |
2. 4.2 Industrial Automation & Equipment, BY Delivery Mode (USD Million) | |
  1. 4.2.1 Software | |
  2. 4.2.2 Device | |
  3. 4.2.3 Platform |
3. 4.3 Industrial Automation & Equipment, BY End User (USD Million) | |
  1. 4.3.1 Patients | |
  2. 4.3.2 Providers | |
  3. 4.3.3 Payers | |
  4. 4.3.4 Employers |
4. 4.4 Industrial Automation & Equipment, BY Therapeutic Area (USD Million) | |
  1. 4.4.1 Diabetes | |
  2. 4.4.2 Cardiology | |
  3. 4.4.3 Neurology | |
  4. 4.4.4 Oncology 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Omada Health (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Pear Therapeutics (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Big Health (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Akili Interactive (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 DarioHealth (IL) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 WellDoc (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Livongo Health (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Mytonomy (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY APPLICATION |
6. 6.3 US MARKET ANALYSIS BY DELIVERY MODE |
7. 6.4 US MARKET ANALYSIS BY END USER |
8. 6.5 US MARKET ANALYSIS BY THERAPEUTIC AREA |
9. 6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT |
12. 6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT |
14. 6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT |
15. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 (% SHARE) |
16. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 TO 2035 (USD Million) |
17. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DELIVERY MODE, 2024 (% SHARE) |
18. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DELIVERY MODE, 2024 TO 2035 (USD Million) |
19. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 (% SHARE) |
20. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 TO 2035 (USD Million) |
21. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY THERAPEUTIC AREA, 2024 (% SHARE) |
22. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million) | |
  2. 7.2.2 BY DELIVERY MODE, 2025-2035 (USD Million) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Million) | |
  4. 7.2.4 BY THERAPEUTIC AREA, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Digital Therapeutics Market Segmentation

US Digital Therapeutics Market By Application (USD Million, 2025-2035)

Chronic Disease Management
Mental Health Disorders
Preventive Care
General Wellness

US Digital Therapeutics Market By Delivery Mode (USD Million, 2025-2035)

Software
Device
Platform

US Digital Therapeutics Market By End User (USD Million, 2025-2035)

Patients
Providers
Payers
Employers

US Digital Therapeutics Market By Therapeutic Area (USD Million, 2025-2035)

Diabetes
Cardiology
Neurology
Oncology

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”